Abel Hall LLC’s Dentsply Sirona XRAY Stock Holding History

Abel Hall LLC’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,932	Closed	-$148K	–	985
2025 Q4	$148K	Buy	+12,932	New	+$152K	0.03%	582

Other funds holding XRAY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Abel Hall LLC's XRAY Position: Q1 2026 in Review

Abel Hall LLC sold out of Dentsply Sirona (XRAY) in Q1 2026, closing a stake of 12,932 shares — an estimated $148K sold.

Abel Hall LLC first reported a position in XRAY in Q4 2025 and held it in 1 quarter. The position peaked at $148K in Q4 2025. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

Abel Hall LLC reported no remaining Dentsply Sirona position as of Q1 2026 after selling out during the quarter.
Abel Hall LLC sold 12,932 Dentsply Sirona shares in Q1 2026, an estimated $148K.
Abel Hall LLC first reported a position in Dentsply Sirona in Q4 2025 and held it in 1 quarter.
Abel Hall LLC's Dentsply Sirona position peaked at $148K in Q4 2025.
382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.